Actively Recruiting
Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation
Led by Medinutra LLC · Updated on 2025-08-01
64
Participants Needed
1
Research Sites
19 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Two dietary supplements are each being compared to a placebo for the ability to help maintain triglycerides in the normal range. The subjects will be adult men and women with moderately high TG values. Serum triglycerides will be measured before and after 6 weeks of taking 1 capsule per day of either Longvida Curcumin, astaxanthin, or a placebo. A few side blood analysis will also be done. These measures are relevant to low level inflammation.
CONDITIONS
Official Title
Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Triglyceride reading of 140-250 mg/dL
- Age 21-59 years
You will not qualify if you...
- Uncontrolled diabetes
- Hypothyroidism or other hormonal problems that have not stabilized
- Any liver diseases being actively treated
- Cancer
- Renal dialysis use
- Rheumatoid arthritis and related issues like lupus
- Inflammatory bowel disease
- Smoking
- Low blood pressure
- Having more than 5 alcoholic drinks per week
- Extreme obesity (BMI over 37)
- Pregnancy or lactation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medinutra LLC
Dublin, Ohio, United States, 43016
Actively Recruiting
Research Team
R
Robert DiSilvestro, Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here